secwatch.observer — SEC 8-K summary
======================================

Issuer:     MetaVia Inc. (MTVA)
CIK:        0001638287
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001558370-23-013944
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroBo gets 180-day Nasdaq bid-price extension to Feb 5, 2024; still below $1.00
--------------------------------------------------------------------------------

- Nasdaq granted 180-day extension to Feb 5, 2024 to regain $1.00 minimum bid price.
- Stockholders approved reverse stock split (1:5 to 1:8) on June 28, 2023; board may implement.
- If not compliant by Feb 5, 2024, Nasdaq will issue delisting notice; company can appeal.
- Updated risk factors highlight potential delisting impact on liquidity and capital raising.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638287/000155837023013944/0001558370-23-013944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638287/000155837023013944/nrbo-20230808x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-013944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer